# Kansas Bioscience Authority

Kansas Bioscience Authority is a Foundation based in Olathe, United States.

## Overview

- **Organization type:** Foundation
- **Headquarters:** Olathe, United States
- **Region:** North America
- **Address:** Olathe, KS, United States
- **Founded:** 2004
- **Assets under management:** Undisclosed
- **Website:** http://www.kansasbioauthority.org
- **LinkedIn:** https://www.linkedin.com/company/kansas-bioscience-authority

## Regulatory record

- **Reports private funds:** No

## About

The Kansas Bioscience Authority was established by the Kansas Economic Growth Act of 2004. It invests in bioscience research to expand Kansas' capabilities. The KBA has made 19 investments, including a 2016 investment in OptiKira.

## Sectors

- Life Sciences
- Biotechnology
- AgriTech & FoodTech
- Digital Health
- Industrial Tech

## Offices

- Basel, Switzerland
- Chicago, IL
- Washington, D.C.
- Durham, NC
- Burlington, MA

## Questions

### Who makes investment decisions at the Kansas Bioscience Authority?

KBA is governed by a board of directors appointed by the Kansas governor and legislative leaders. The board sets investment strategy and approves major commitments. Day-to-day investment management is handled by a professional staff, though specific named executives are not publicly listed. (per KBA state statute, 2004)

### How does KBA source proprietary deal flow?

KBA sources deals through its network of university research partners — including the University of Kansas Medical Center and Kansas State University's College of Veterinary Medicine — as well as through direct outreach to Kansas-based bioscience startups. It also receives referrals from venture capital firms active in the region. (per Kansas City Business Journal, 2022)

### Is KBA structured as a venture capital firm or a government agency?

KBA is a hybrid — a state-chartered public authority that operates with venture-like investment discipline. It can take equity positions, make direct investments, and seek financial returns, but it was created by state legislation and is beholden to public oversight. Its mandate is economic development, not maximizing return. (per KBA enabling statute, 2004)

### What investment stages does KBA typically target?

KBA invests across the full spectrum of bioscience development — from early-stage university research grants and seed rounds to growth-stage venture capital and commercialization support. It often fills gaps where private capital is scarce, such as translational research or first-in-human clinical trials. (per Kansas City Business Journal, 2022)

### Which sectors does KBA explicitly avoid?

KBA's mandate limits investments to bioscience and related technologies. It does not invest in software, financial services, real estate, or other non-bioscience sectors. Within bioscience, it focuses on human and animal health, agriculture, and industrial biotechnology. (per KBA enabling statute, 2004)

## Related profiles

- [Axioma](https://altss.com/profile/axioma)
- [Pacific Market International](https://altss.com/profile/pacific-market-international)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/kansas-bioscience-authority

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology